Rheumatoid arthritis is a debilitating disease afflicting millions of Americans;it also causes a significant economic burden. Recently this disease has been associated with aberrant T helper-17 (Th17) responses. Adaptive immune responses have long been thought to be dominated by either Th1 or Th2 cells. More recently, however, Th17 cells have been discovered;these cells are critical in defense against many extracellular bacteria and fungi, but they have also been found to drive a number of inflammatory and autoimmune diseases, including rheumatoid arthritis. IL-17 (aka IL-17A) is the signature cytokines of Th17 cells and the importance of this cytokine in arthritis has been revealed with mouse models. Mice lacking IL-17A exhibit an ameliorated pathology in the collagen-induced arthritis (CIA) model. However there is evidence implicating a role for other members of the IL-17 cytokine in CIA, including IL-17F, which is closely related to IL-17A. Therefore it is imperative to explore whether blocking the signaling by all members of this cytokine family could be a therapeutic strategy. The CIKS adaptor protein is essential to signaling by IL-17 cytokines. To test whether this adaptor might be a useful therapeutic target, we generated mice lacking CIKS and subjected them to collagen-induced arthritis. We discovered that these mice are totally protected from CIA. This result provides a proof-of-principle indicating that CIKS is a possible target for therapeutic intervention in rheumatoid arthritis. Importantly we also were able to demonstrate that the absence of CIKS mediated signaling also significantly depressed antibody production to collagen, suggesting that IL-17 cytokines may have a previously unsuspected role in auto-antibody production.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2010
Total Cost
$890,333
Indirect Cost
City
State
Country
Zip Code
Das, Nitin A; Carpenter, Andrea J; Yoshida, Tadashi et al. (2018) TRAF3IP2 mediates TWEAK/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart. J Mol Cell Cardiol 121:107-123
Break, Timothy J; Desai, Jigar V; Healey, Kelley R et al. (2018) VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice. J Antimicrob Chemother 73:2089-2094
Break, Timothy J; Desai, Jigar V; Natarajan, Mukil et al. (2018) VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans. J Antimicrob Chemother 73:151-155
Padilla, Jaume; Carpenter, Andrea J; Das, Nitin A et al. (2018) TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells. Am J Physiol Heart Circ Physiol 314:H52-H64
Erikson, John M; Valente, Anthony J; Mummidi, Srinivas et al. (2017) Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling. J Biol Chem 292:2345-2358
Whibley, Natasha; Tritto, Elaine; Traggiai, Elisabetta et al. (2016) Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis. J Leukoc Biol 99:1153-64
Mummidi, Srinivas; Das, Nitin A; Carpenter, Andrea J et al. (2016) Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo. J Mol Cell Cardiol 98:95-102
Sakamuri, Siva S V P; Valente, Anthony J; Siddesha, Jalahalli M et al. (2016) TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis. Mol Cell Endocrinol 429:84-92
Yariswamy, Manjunath; Yoshida, Tadashi; Valente, Anthony J et al. (2016) Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction. J Biol Chem 291:19425-36
Sakamuri, Siva Sankara Vara Prasad; Higashi, Yusuke; Sukhanov, Sergiy et al. (2016) TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) mice. Atherosclerosis 252:153-160

Showing the most recent 10 out of 28 publications